NATICK, MA (PRWEB) October 21, 2016
InfuTronix, LLC, a global medical device manufacturer focused on developing the next generation ambulatory infusion pumps will feature the Nimbus™ PainPRO ambulatory infusion system at this year’s American Society of Anesthesiologists Annual Conference, October 22-26 in Chicago, IL.
"We are excited by the announcement of our recently expanded FDA 510(k) clearance for the Nimbus infusion platform,” said John LaFratta, Director of Sales and Business Development at InfuTronix. “The latest ruling establishes a pathway for the expanded launch of a family of Nimbus infusion devices intended to cover an even larger share of the Regional Anesthesia/Analgesia market offering devices dedicated to the inpatient continuous peripheral nerve block market, outpatient CPNB market, as well as a soon to be launched Nimbus PCEA infusion pump targeting Labor & Delivery.”
The Nimbus PainPRO is the newest and the most innovative ambulatory pump to enter the industry. Whether your choice is for your pump to be reusable or recyclable, Nimbus™ is adaptable to any environment and it affords the sophistication of a high-end electronic pump designed and priced to compete in the disposable market. Its smart capabilities and enhanced mobility create a comfortable, seamless, and unobtrusive recuperation postoperative analgesia experience.
The pre-programmed, intermittent AutoBolus protocols of Nimbus™ deliver “top off” dosing, intended to optimize the spread of local anesthetic to bathe the target nerves. Not only can Nimbus provide personalized pain control with the Patient Demand Bolus feature, but Nimbus also enables an extension of pain control for up to 24 hours longer by suspending the start of the therapy until the surgical block begins to wear off. Additionally, the Nimbus™ PainPRO affords continuous basal flow rate between 0– 14 mL/hr with minimal variance and allows the control to titrate on the fly. With a performance battery life of 240 hours, it enables extended therapy durations and increased pain management solutions.
The Nimbus PainPRO is intended for subcutaneous, percutaneous, perineural, epidural, and intravenous infusion, including but not limited to patient controlled analgesia (PCA) delivery in clinical and non-clinical environments, such as homes.
About InfuTronix, LLC
Infutronix is a leading infusion pump company aiming to increase patient safety and streamline clinical workflow. It provides a portfolio of ambulatory infusion pump products designed to increase customer satisfaction and enhance patient safety in a cost effective solution. InfuTronix’s market focus is acute care pain management where there is a need for easy-to-use high-end electronic infusion pumps that have a high level of accuracy and flexibility for the unique needs of the ambulatory pump user. The mission of InfuTronix is to design forward-thinking devices that are capable of setting standards in the evolving pain management programs while understanding the current market needs. Infutronix is headquartered in Natick, Massachusetts. For more information, please visit http://www.nimbuspump.com.